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Background
Bronchopulmonary dysplasia (BPD) is the most common respiratory morbidity
after preterm birth but requires diagnosis near corrected full-term age. Postnatal
dexamethasone is often used to improve lung function. Yet objective measures of
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Proportion of severe (type 2)
BPD or death by Risk Score.
Baseline model includes
demographic and steroid
factors only, Model includes

steroid response remain lacking. An understanding of steroid response holds

elements quantifying

significant promise as a surrogate endpoint for new therapies.

ventilatory change from
baseline with dexamethasone

Objective

treatment and demographics.

To create a quantitative measure of clinical response following Dexamethasone

Boxplots represent proportion

administration and association to downstream BPD classification at 36-weeks.

of infants with BPD severe
(type 2) or death labeled with

Design/Methods
• A retrospective chart review was performed of preterm infants treated with the
DART protocol at Children’s Mercy’s Level IV NICU 2010-2020
• Data (Table) was collected at key timepoints (Day 1, 3, 7) for each infant

each risk level by the respective
models over 10,000 bootstrap
iterations. Open circles
represent proportion estimates
outside of 1.5 x interquartile
range for each model.

o Ventilation mode was defined as either high frequency oscillatory,
conventional invasive, or any form of non-invasive support. Highest daily
mode was recorded.
o Support level was measured by respiratory severity score (RSS= MAP*FiO2).
• BPD outcomes were defined according to the 2017 BPD Collaborative definition.
o Composite of mild, moderate, or severe (type 1) BPD was used as referent
group to assess odds against severe (type 2) BPD or death.
• A regularized logistic model was fitted and resulting predicted probabilities were
divided into quartiles to obtain a discrete risk level (level 1 to 4).
Demographics

Steroid Details

• Gestational age • Age of steroid
• Sex
initiation
• Strength Course
Length

Response Data
• Baseline (Day 1) & percent change
from baseline (Day 7 vs Day 1)
• RSS, pCO2
• Ventilator mode change from baseline

Conclusions

Results
• Study cohort included 94 infants with complete ventilatory and blood gas data
and who completed a DART course prior to 36-week BPD assessment.
• A 10,000-iteration bootstrap was performed. A risk score was predicted for
infants not included in the resampled data at each iteration and the proportion
of those with severe (type 2) BPD or death at each level was evaluated (Figure).

• Changes in ventilatory parameters over the course of dexamethasone
administration improved BPD prediction compared to baseline demographics
alone.
• Incorporating drug response phenotype into a BPD model may enable more
rapid development of future therapeutics.

o For comparison, predictions were also made with a baseline model using
only demographic and steroid detail data.
• Increasing risk category was well aligned with rising outcome incidence, ranging
from ~20% of infants at level 1 to ~55% of infants at level 4.
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